Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
The Prostate|May 31, 2021
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patternsChristoph Würnschimmel, Mike Wenzel, Francesco Chierigo, et al.
Cancer Causes & Control : CCC|September 3, 2021
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinomaMike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
Urologic Oncology|August 30, 2021
Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltrationBenedikt Hoeh, Felix Preisser, Mike Wenzel, et al.
Frontiers in Surgery|March 11, 2022
Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Lukas Hohenhorst, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Prostate Cancer and Prostatic Diseases|March 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysisMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
The Prostate|May 31, 2021
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patternsChristoph Würnschimmel, Mike Wenzel, Francesco Chierigo, et al.
Cancer Causes & Control : CCC|September 3, 2021
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinomaMike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical ProstatectomyMike Wenzel, Felix Preisser, Clarissa Wittler, et al.
Journal of Robotic Surgery|April 23, 2022
Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomyBenedikt Hoeh, Jan L Hohenhorst, Mike Wenzel, et al.
Pageof 22